CCO Treatment Updates
New Management Strategies for HCV Nonresponders and Relapsers
Module
Understanding HCV Nonresponse and Identifying Candidates for Retreatment
|
|
|
Mitchell L. Shiffman, MD, reviews the various types of virologic response in hepatitis C virus–infected patients treated with interferon and ribavirin-based regimens and explains how to identify patients who would be good candidates for retreatment if they fail to achieve sustained virologic response.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Specify standard definitions of response and nonresponse to hepatitis C virus therapy
- Discuss factors associated with nonresponse to hepatitis C virus therapy
- Report criteria that may help to identify nonresponders who are good candidates for retreatment
- Summarize data from studies of different retreatment strategies
- Describe appropriate virologic goals of therapy for nonresponders undergoing retreatment
|
Interactive Case Challenge
Retreatment of a Patient With Chronic HCV Infection and Previous Treatment Failure
- Tarek Hassanein, MD, FACP, FACG, AGAF
|
|
|
Tarek Hassanein, MD, reviews management strategies for optimizing future therapy success in a HCV-infected patient with previous partial treatment response on a standard interferon-based regimen.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Specify standard definitions of response and nonresponse to hepatitis C therapy
- Discuss factors associated with nonresponse to hepatitis C therapy
- Report criteria that may help to identify nonresponders who are good candidates for retreatment
- Summarize data from studies of different retreatment strategies
- Describe appropriate virologic goals of therapy for nonresponders undergoing retreatment
|
Slideset Module
New Management Strategies for HCV Nonresponders and Relapsers
|
|
|
Mitchell L. Shiffman, MD, reviews the various types of virologic response in patients treated for hepatitis C virus infection, discusses what factors are associated with better responses, and summarizes the most recent data available on various retreatment strategies.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Specify standard definitions of response and nonresponse to hepatitis C virus therapy
- Discuss factors associated with nonresponse to hepatitis C virus therapy
- Report criteria that may help to identify nonresponders who are good candidates for retreatment
- Summarize data from studies of different retreatment strategies
- Describe appropriate virologic goals of therapy for nonresponders undergoing retreatment
|
Slideset: New Management Strategies for HCV Nonresponders and Relapsers
 |
|
Format: Microsoft PowerPoint (.ppt) |
File size: 1.12 MB
| Date posted: 12/5/2007
|
On-Demand Teleconference
Download Audio from Teleconference
|
|
|
Mitchell L. Shiffman, MD, reviews the various types of virologic response in patients treated for hepatitis C virus infection, discusses what factors are associated with better responses, and summarizes the most recent data available on various retreatment strategies.
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|